| [1] |
陈万青, 孙可欣, 郑荣寿, 等. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 27(1): 1-14.
|
| [2] |
杜灵彬, 李辉章, 王悠清, 等. 2013年中国结直肠癌发病与死亡分析[J]. 中华肿瘤杂志, 2017, 39(9): 701-706.
|
| [3] |
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations[J]. Cancer, 1994, 73(11): 2680-2686.
|
| [4] |
Dworak O,Keilholz L, and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy[J]. Int J Colorectal Dis, 1997, 12(1): 19-23.
|
| [5] |
Wheeler JM, Warren BF, Mortensen NJ, et al. Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system[J]. Dis Colon Rectum, 2002, 45(8): 1051-1056.
|
| [6] |
Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer[J]. Histopathology, 2005, 47(2): 141-146.
|
| [7] |
Peng H, Wang C, Xiao W, et al. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy[J]. J Cancer, 2018, 9(15): 2687-2692.
|
| [8] |
Song J, Huang X, Chen Z, et al. Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0-I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J]. Cancer Manag Res, 2018(10): 3101-3108.
|
| [9] |
Dudani S, Marginean H, Tang PA, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation[J]. BMC Cancer, 2019, 19(1): 664.
|
| [10] |
Rampazzo E, Del Bianco P, Bertorelle R, et al. The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients[J]. Br J Cancer, 2018, 118(6): 878-886.
|
| [11] |
Troncarelli Flores BC, Souza E Silva V, Ali Abdallah E, et al. Molecular and kinetic analyses of circulating tumor cells as predictive markers of treatment response in locally advanced rectal cancer patients[J]. Cells, 2019, 8(7): 641.
|
| [12] |
Sun W, Huang T, Li G, et al. The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer[J]. Future Oncol, 2013, 9(10): 1489-1500.
|
| [13] |
Sun W, Jia C, Huang T, et al. High-performance size-based microdevice for the detection of circulating tumor cells from peripheral blood in rectal cancer patients[J]. PLoS One, 2013, 8(9): e75865.
|
| [14] |
Braun LH, Baumann D, Zwirner K, et al. Neutrophil-to-lymphocyte ratio in rectal cancer-novel biomarker of tumor immunogenicity during radiotherapy or confounding variable?[J]. Int J Mol Sci, 2019, 20(10): 2448.
|
| [15] |
Lai S, Huang L, Luo S, et al. Systemic inflammatory indices predict tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer[J]. Oncol Lett, 2020, 20(3): 2763-2770.
|
| [16] |
Xiao B, Peng J, Zhang R, et al. Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer[J]. Cancer Manag Res, 2017, 27(9):701-708.
|
| [17] |
Yu J, Lee SH, Jeung TS, et al. Expression of vascular endothelial growth factor as a predictor of complete response for preoperative chemoradiotherapy in rectal cancer[J]. Medicine (Baltimore), 2019, 98(26): e16190.
|
| [18] |
Belluco C, Forlin M, Delrio P, et al. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients[J]. BMC Cancer, 2018, 18(1): 1094.
|
| [19] |
Zhou J, Wang C, Lin G, et al. Serial circulating tumor DNA in predicting and monitoring the effect of neoadjuvant chemoradiotherapy in patients with rectal cancer: A prospective multicenter study[J]. Clin Cancer Res, 2021, 27(1): 301-310.
|
| [20] |
曹冬梅, 卢建. 叉头框(Fox)转录因子家族的结构与功能[J]. 生命科学, 2006, 18(5): 491-496.
|
| [21] |
Zhang Y, Xu M, Chen J, et al. Prognostic value of the FOXK family expression in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy[J]. Onco Targets Ther, 2020(13): 9185-9201.
|
| [22] |
Kamran SC, Lennerz JK, Margolis CA, et al. Integrative molecular characterization of resistance to neoadjuvant chemoradiation in rectal cancer[J]. Clin Cancer Res, 2019, 25(18): 5561-5571.
|
| [23] |
Wan JF, Li XQ, Zhang J, et al. Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer[J]. Oncol Lett, 2018, 16(2): 1863-1868.
|
| [24] |
do Canto LM, Barros-Filho MC, Rainho CA, et al. Comprehensive analysis of DNA methylation and prediction of response to neoadjuvant therapy in locally advanced rectal cancer[J]. Cancers (Basel), 2020, 12(11): 3079.
|
| [25] |
Machackova T, Trachtova K, Prochazka V, et al. Tumor microRNAs identified by small RNA sequencing as potential response predictors in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy[J]. Cancer Genomics Proteomics, 2020, 17(3): 249-257.
|
| [26] |
Cristóbal I, Rubio J, Santos A, et al. MicroRNA-199b downregulation confers resistance to 5-fluorouracil treatment and predicts poor outcome and response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients[J]. Cancers (Basel), 2020, 12(6): 1655.
|
| [27] |
Du B, Wang X, Wu D, et al. MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer[J]. Mol Med Rep, 2018, 18(2): 1909-1916.
|
| [28] |
Campayo M, Navarro A, Benítez JC, et al. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer[J]. PLoS One, 2018, 13(11): e0206542.
|
| [29] |
Yokoyama Y, Sakatani T, Wada R, et al. In vitro and in vivo studies on the association of long non-coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5-fluorouracil in rectal cancer[J]. Int J Oncol, 2019, 55(6): 1361-1371.
|
| [30] |
Ma WJ, Gu YK, Peng JH, et al. Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy[J]. Aging (Albany NY), 2018, 10(10): 2755-2771.
|
| [31] |
Chang IW, Liu KW, Ragunanan M, et al. SERPINB5 Expression: Association with CCRT response and prognostic value in rectal cancer[J]. Int J Med Sci, 2018, 15(4): 376-384.
|
| [32] |
Ferrandon S, DeVecchio J, Duraes L, et al. CoA synthase (COASY) mediates radiation resistance via PI3K signaling in rectal cancer[J]. Cancer Res, 2020, 80(2): 334-346.
|
| [33] |
Yan X, Chen J, Meng Y, et al. RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9-caspase-3-dependent apoptotic pathway[J]. Cancer Med, 2019, 8(6): 3094-3104.
|
| [34] |
Zhang RX, Zhou ZG, Lu SX, et al. Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients[J]. Sci Rep, 2017, 7(1): 16043.
|
| [35] |
Bowden DL, Sutton PA, Wall MA, et al. Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response[J]. J Proteomics, 2018(179): 53-60.
|
| [36] |
Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, et al. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer[J]. BMC Cancer, 2018, 18(1):144.
|
| [37] |
Kim JY, Park SG, Kim KS, et al. The Krüppel-like factor (KLF5) as a predictive biomarker in preoperative chemoradiation therapy for rectal cancer[J]. Ann Surg Treat Res, 2019, 97(2): 83-92.
|
| [38] |
Akiyoshi T, Tanaka N, Kiyotani K, et al. Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer[J]. Br J Surg, 2019, 106(10): 1381-1392.
|
| [39] |
Matsutani S, Shibutani M, Maeda K, et al. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer[J]. Cancer Sci, 2018, 109(4): 966-979.
|
| [40] |
Hasan S, Renz P, Wegner RE, et al. Microsatellite instability (MSI) as an independent predictor of pathologic complete response (PCR) in locally advanced rectal cancer: A national cancer database (NCDB) analysis[J]. Ann Surg, 2020, 271(4): 716-723.
|
| [41] |
Jimenez L, Perez RO, São Julião GP, et al. Prediction of poor response to neoadjuvant chemoradiation in patients with rectal cancer using a DNA repair deregulation score: picking the losers instead of the winners[J]. Dis Colon Rectum, 2020, 63(3): 300-309.
|
| [42] |
Peng J, Ma W, Zhou Z, et al. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery[J]. J Cancer, 2018, 9(6): 1067-1077.
|
| [43] |
Chao X, Wang Z, Lu S, et al. Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer[J]. Int J Clin Oncol, 2020, 25(9): 1653-1662.
|
| [44] |
Sottoriva A, Kang H, Ma Z, et al. A Big Bang model of human colorectal tumor growth[J]. Nat Genet, 2015, 47(3): 209-216.
|